Amoy Diagnostics released the third quarter report of 2024, achieving revenue of 0.848 billion yuan in the first three quarters, a year-on-year increase of 19.84%; net income attributable to shareholders of the listed company was 0.227 billion yuan, a year-on-year increase of 30.82%; basic earnings per share were 0.57 yuan. In the third quarter, revenue reached 0.305 billion yuan, a year-on-year increase of 22.53%; net income attributable to shareholders of the listed company was 83.414 million yuan, a year-on-year increase of 77.58%. The company stated that the performance growth was mainly due to revenue growth and effective implementation of management philosophy focusing on cost control, quality improvement, and efficiency enhancement.